These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 27019699)

  • 1. The importance of understanding individual differences in Down syndrome.
    Karmiloff-Smith A; Al-Janabi T; D'Souza H; Groet J; Massand E; Mok K; Startin C; Fisher E; Hardy J; Nizetic D; Tybulewicz V; Strydom A
    F1000Res; 2016; 5():. PubMed ID: 27019699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further understanding the connection between Alzheimer's disease and Down syndrome.
    Snyder HM; Bain LJ; Brickman AM; Carrillo MC; Esbensen AJ; Espinosa JM; Fernandez F; Fortea J; Hartley SL; Head E; Hendrix J; Kishnani PS; Lai F; Lao P; Lemere C; Mobley W; Mufson EJ; Potter H; Zaman SH; Granholm AC; Rosas HD; Strydom A; Whitten MS; Rafii MS
    Alzheimers Dement; 2020 Jul; 16(7):1065-1077. PubMed ID: 32544310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study.
    Fagan AM; Henson RL; Li Y; Boerwinkle AH; Xiong C; Bateman RJ; Goate A; Ances BM; Doran E; Christian BT; Lai F; Rosas HD; Schupf N; Krinsky-McHale S; Silverman W; Lee JH; Klunk WE; Handen BL; Allegri RF; Chhatwal JP; Day GS; Graff-Radford NR; Jucker M; Levin J; Martins RN; Masters CL; Mori H; Mummery CJ; Niimi Y; Ringman JM; Salloway S; Schofield PR; Shoji M; Lott IT; ;
    Lancet Neurol; 2021 Aug; 20(8):615-626. PubMed ID: 34302786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging With Down Syndrome: The Dual Diagnosis: Alzheimer's Disease and Down Syndrome.
    Cipriani G; Danti S; Carlesi C; Di Fiorino M
    Am J Alzheimers Dis Other Demen; 2018 Jun; 33(4):253-262. PubMed ID: 29504408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing Paradigms in Down Syndrome: The First International Conference of the Trisomy 21 Research Society.
    Delabar JM; Allinquant B; Bianchi D; Blumenthal T; Dekker A; Edgin J; O'Bryan J; Dierssen M; Potier MC; Wiseman F; Guedj F; Créau N; Reeves R; Gardiner K; Busciglio J
    Mol Syndromol; 2016 Oct; 7(5):251-261. PubMed ID: 27867340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-level developmental approach to exploring individual differences in Down syndrome: genes, brain, behaviour, and environment.
    Thomas MSC; Ojinaga Alfageme O; D'Souza H; Patkee PA; Rutherford MA; Mok KY; Hardy J; Karmiloff-Smith A;
    Res Dev Disabil; 2020 Sep; 104():103638. PubMed ID: 32653761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome.
    Gorijala P; Aslam MM; Dang LT; Xicota L; Fernandez MV; Sung YJ; Fan KH; Feingold E; Surace EI; Chhatwal JP; Hom CL; ; ; Hartley SL; Hassenstab J; Perrin RJ; Mapstone M; Zaman SH; Ances BM; Kamboh MI; Lee JH; Cruchaga C
    Alzheimers Dement; 2024 Feb; 20(2):1038-1049. PubMed ID: 37855447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical aging in Down syndrome.
    Zigman WB
    Dev Disabil Res Rev; 2013; 18(1):51-67. PubMed ID: 23949829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periodontal disease's contribution to Alzheimer's disease progression in Down syndrome.
    Kamer AR; Fortea JO; Videla S; Mayoral A; Janal M; Carmona-Iragui M; Benejam B; Craig RG; Saxena D; Corby P; Glodzik L; Annam KR; Robbins M; de Leon MJ
    Alzheimers Dement (Amst); 2016; 2():49-57. PubMed ID: 27239536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing the progression of Alzheimer's disease in Down syndrome patients with micro-dose lithium.
    Priebe GA; Kanzawa MM
    Med Hypotheses; 2020 Apr; 137():109573. PubMed ID: 31986471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down syndrome and Alzheimer's disease: Common pathways, common goals.
    Hartley D; Blumenthal T; Carrillo M; DiPaolo G; Esralew L; Gardiner K; Granholm AC; Iqbal K; Krams M; Lemere C; Lott I; Mobley W; Ness S; Nixon R; Potter H; Reeves R; Sabbagh M; Silverman W; Tycko B; Whitten M; Wisniewski T
    Alzheimers Dement; 2015 Jun; 11(6):700-9. PubMed ID: 25510383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
    Gautier MK; Kelley CM; Lee SH; Alldred MJ; McDaid J; Mufson EJ; Stutzmann GE; Ginsberg SD
    Neurobiol Dis; 2023 Nov; 188():106332. PubMed ID: 37890559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21.
    Lyle R; Béna F; Gagos S; Gehrig C; Lopez G; Schinzel A; Lespinasse J; Bottani A; Dahoun S; Taine L; Doco-Fenzy M; Cornillet-Lefèbvre P; Pelet A; Lyonnet S; Toutain A; Colleaux L; Horst J; Kennerknecht I; Wakamatsu N; Descartes M; Franklin JC; Florentin-Arar L; Kitsiou S; Aït Yahya-Graison E; Costantine M; Sinet PM; Delabar JM; Antonarakis SE
    Eur J Hum Genet; 2009 Apr; 17(4):454-66. PubMed ID: 19002211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diseases Affecting Middle-Aged and Elderly Individuals With Trisomy 21.
    Levin J; Hasan A; Alejandre IA; Lorenzi I; Mall V; Rohrer TR
    Dtsch Arztebl Int; 2023 Jan; 120(1-2):14-24. PubMed ID: 36468261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma metabolites related to cellular energy metabolism are altered in adults with Down syndrome and Alzheimer's disease.
    Gross TJ; Doran E; Cheema AK; Head E; Lott IT; Mapstone M
    Dev Neurobiol; 2019 Jul; 79(7):622-638. PubMed ID: 31419370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose.
    Chen XQ; Zuo X; Becker A; Head E; Mobley WC
    Alzheimers Dement; 2023 May; 19(5):2095-2116. PubMed ID: 36370135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome.
    Duchon A; Herault Y
    Front Behav Neurosci; 2016; 10():104. PubMed ID: 27375444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down syndrome.
    Rafii MS; Kleschevnikov AM; Sawa M; Mobley WC
    Handb Clin Neurol; 2019; 167():321-336. PubMed ID: 31753140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetic analysis of Down syndrome.
    Patterson D
    Hum Genet; 2009 Jul; 126(1):195-214. PubMed ID: 19526251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial trisomy 21 with or without highly restricted Down syndrome critical region (HR-DSCR): report of two new cases and reanalysis of the genotype-phenotype association.
    Pelleri MC; Locatelli C; Mattina T; Bonaglia MC; Piazza F; Magini P; Antonaros F; Ramacieri G; Vione B; Vitale L; Seri M; Strippoli P; Cocchi G; Piovesan A; Caracausi M
    BMC Med Genomics; 2022 Dec; 15(1):266. PubMed ID: 36544206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.